Hallucinogen use among inmates at a US county jail was associated with a reduced likelihood of arrest for intimate partner violence (IPV). In a prospective study of 302 inmates, those who used hallucinogens were about 40% less likely to be arrested for IPV, both before and after accounting for other factors. The findings add to evidence that hallucinogens may help reduce problematic behaviors linked to externalizing psychopathology, such as substance misuse and criminality.
Psychospiritual distress causes profound suffering in people with serious illness, yet treatment options are few. A palliative care-embedded ketamine-assisted psychotherapy (KAP) program called Pal-KAP was developed and delivered at an academic medical center. Between May 2023 and September 2025, 59 patients were referred for screening; 43 met eligibility criteria, and 30 elected to participate. Patients (age 19-76, mean 53) completed a median of 1.5 medicine sessions (range 1-5). Most had cancer (80%) or neurological disease (13.3%). Ketamine dose averaged 0.93 mg/kg intramuscularly, with minor adverse effects and no serious adverse events. This experience suggests that KAP can be delivered safely and ethically in palliative care.